The image above is used in social media to direct the audience to yourpharmacist.org.


HOPA is pleased to be an official supporter of ASHP’s We’re Your Pharmacist, a national public awareness campaign bringing visibility to pharmacist contributions to patient care across practice settings and specialties.

Along with the ASHP and other campaign supporters, HOPA will help educate the public about pharmacist patient care roles and inspire the next generation of pharmacy professionals.

In it's first year, We’re Your Pharmacist exceeded expectations in its reach and impact. According to ASHP, the campagin garnered more than 87 million digital impressions, 1.8 million+ social media engagements, and more than 120,000 visits to the campaign website.

This campaign aligns with HOPA's vision that everyone undergoing cancer treatment should have an oncology pharmacist as an integral part of their care team.

It also helps expand our reach as we combine efforts with other supporters, including the American Association of Colleges of Pharmacy (AACP), American Association of Psychiatric Pharmacists (AAPP), and the Board of Pharmacy Specialties (BPS).

Want to increase public awareness of pharmacists?

About ASHP

ASHP is the largest association of pharmacy professionals in the United States, representing 60,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. ASHP innovates, educates, and advocates for a strong pharmacy profession. Visit ashp.org.

U.S. Capitol Building
Advocacy

What HOPA Members Should Know About the End of the 2025 U.S. Government Shutdown

On Wednesday, November 12, Congress passed a continuing resolution to re-open the government after a record 43-day shutdown. Here's what HOPA members should know about the bill and what's happening next.

Map of the sub-Saharan African region
Advocacy

HOPA Endorses ISOPP & UICC Statement on Ensuring International Cancer Drug Quality and Equity

ISOPP and UICC recently released a statement calling for quality and equity of cancer treatments in sub-Saharan Africa. HOPA has joined with oncology and pharmacy organizations worldwide to endorse their statement.

Images of DNA strands for DPYD genetic testing
Advocacy

HOPA Supports FDA Box Label Changes for DPYD Testing

We support the FDA's updated guidance concerning DPD deficiency and fluoropyrimidine drugs, and urge healthcare providers to integrate DPYD genetic testing into clinical practice.